Design, production and evaluation of novel diagnostic and therapeutic reagents. 6-9 December 1999, La Jolla, CA, USA
{{output}}
The timing of this meeting was indeed auspicious; the antibody engineers were able to celebrate the end of the decade and millennium with the launch of several dominant biotechnology products. Currently, over 30% of all new protein-based therapeutic products b... ...
